Product Information
ENTECAVIR 1 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.3501 per EA under NDC 69097042502. Its NADAC has been published 485 times since Mar 15, 2017.
Strength
1 mg/1
Manufacturer
Cipla USA Inc.NDC
69097042502
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ENTECAVIRApproval Type
Generic (ANDA)
FDA Application
ANDA206872On Market Since
12/6/2016
Pharmacological Classes
Price Statistics
The NADAC for ENTECAVIR 1 MG TABLET has been published 485 times since Mar 15, 2017, and over the history we have for it it has declined 95.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3501 per EA |
|---|---|
| All-time high | $9.9646 (Apr 12, 2017) |
| All-time low | $0.3119 (Feb 18, 2026) |
| 52-week high | $0.4888 |
| 52-week low | $0.3119 |
| Median price | $1.1782 |
| Average price | $1.7306 |
| Largest weekly change | +93.7% (Jan 19, 2022) |
| Weeks tracked | 485 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ENTECAVIR 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 1 MG TABLET, manufactured by Cipla USA Inc., is $0.3501 per EA (NDC 69097042502), effective Jun 24, 2026.
How has the price of ENTECAVIR 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENTECAVIR 1 MG TABLET has declined 95.9%. It has been tracked across 485 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for ENTECAVIR 1 MG TABLET?
Since Mar 15, 2017, the NADAC for ENTECAVIR 1 MG TABLET has ranged from a low of $0.3119 (Feb 18, 2026) to a high of $9.9646 (Apr 12, 2017), with a median of $1.1782 per EA.
Are there cheaper alternatives to ENTECAVIR 1 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ENTECAVIR 1 MG TABLET, but none are currently priced below it.
Who manufactures ENTECAVIR 1 MG TABLET?
ENTECAVIR 1 MG TABLET (NDC 69097042502) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification